目的:肺纤维化(PF)是一种严重的,进行性疾病,这可能是由于接触某些药物引起的。
方法:我们查询了2000年至2022年的美国FDA不良事件报告系统(FAERS),使用搜索词“肺纤维化”和“特发性肺纤维化”,并排除了18岁以下患者的报告,以及性别或年龄不详的患者。报告按通用药物名称排序,计数,并使用基于指数函数的最佳拟合趋势线随时间绘制。
结果:从2000年到2022年,FAERS报告了24095935起不良药物事件,其中17520(0.07%)被报告为PF。在排除包含年龄不详患者的报告后(5255,30%),性别(122,0.7%),年龄在18岁以下(155,0.9%),我们的研究包括11988例报告.研究样本的平均年龄为66.5±13.1岁,6248例(52.1%)为男性。按年份绘制11988份报告,显示出一条指数最佳拟合线(R2=0.88),随着时间的推移具有正斜率。与PF相关的前五个药物类别是疾病改善抗风湿药(DMARDs,39.4%),抗肿瘤药(26.4%),心血管药物(12.6%),皮质类固醇(4.6%),和免疫抑制剂(4.0%)。
结论:FAERS数据库的23年分析显示PF不良事件报告呈指数增长。发现怀疑患有DMARDs和抗肿瘤剂的PF报告每年显着增加。我们的研究强调了重要的趋势,应用于指导与潜在重要药物相关的PF研究。
OBJECTIVE: Pulmonary fibrosis (PF) is a severe, progressive disease, which may be caused by exposure to certain medications.
METHODS: We queried the U.S. FDA Adverse Event Reporting System (FAERS) from 2000 to 2022, using the search terms \"pulmonary fibrosis\" and \"idiopathic pulmonary fibrosis\" and excluded reports with patients under the age of 18 years, and patients with unknown sex or age. Reports were sorted by generic drug names, counted, and plotted over time using a best-fit trendline based on an exponential function.
RESULTS: From 2000 to 2022, there were 24 095 935 adverse drug events reported in FAERS, of which 17 520 (0.07%) were reported as PF. After excluding reports containing patients with unknown age (5255, 30%), sex (122, 0.7%), and age below 18 years old (155, 0.9%), our study included 11 988 reports. The mean age of the study sample was 66.5 ± 13.1 years, and 6248 patients (52.1%) were male. Plotting the 11 988 reports by year revealed an exponential best fit line (R2 = 0.88) with a positive slope over time. The top five drug classes associated with PF were disease modifying antirheumatic drugs (DMARDs, 39.4%), antineoplastic agents (26.4%), cardiovascular agents (12.6%), corticosteroids (4.6%), and immunosuppressive agents (4.0%).
CONCLUSIONS: A 23-year analysis of the FAERS database revealed exponentially increasing adverse event reports of PF. Significant annual increases in reporting of PF suspected with DMARDs and antineoplastic agents were identified. Our study highlights important trends, which should be used to guide PF research related to drugs of potential importance.